Glucose-insulin-potassium infusion in patients treated with primary angioplasty for acute myocardial infarction: The glucose-insulin-potassium study: A randomized trial

Journal of the American College of Cardiology

Volumn 42, Issue 5, 2003, Pages 784-791

  Van Der Horst, Iwan C C ^a   Zijlstra, Felix ^b   Van't Hof, Arnoud W J ^a   Doggen, Carine J M ^c   De Boer, Menko Jan ^a   Suryapranata, Harry ^a   Hoorntje, Jan C A ^a   Dambrink, Jan Henk E ^a   Gans, Rijk O B ^b   Bilo, Henk J G ^a  

^a HOSPITAL DE WEEZENLANDEN   (Netherlands)

^b UNIVERSITY MEDICAL CENTER GRONINGEN   (Netherlands)

^c LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

GLUCOSE; INSULIN; POTASSIUM;

ACUTE HEART INFARCTION; ADJUVANT THERAPY; ADULT; AGED; ARTICLE; CLINICAL PROTOCOL; CLINICAL TRIAL; CONFIDENCE INTERVAL; CONTINUOUS INFUSION; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CORONARY ARTERY OBSTRUCTION; EVALUATION; FEMALE; GLUCOSE INFUSION; HEART FAILURE; HEART MUSCLE REPERFUSION; HEART PROTECTION; HUMAN; INSULIN INFUSION; MAJOR CLINICAL STUDY; MALE; METABOLIC REGULATION; MORTALITY; OPEN STUDY; OUTCOMES RESEARCH; POTASSIUM INFUSION; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; RISK ASSESSMENT; SURVIVAL RATE; TRANSLUMINAL CORONARY ANGIOPLASTY;

EID: 0042878468     PISSN: 07351097     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0735-1097(03)00830-1     Document Type: Article

References (34)

1. Sodi-Pallares D, Testelli M, Fishleder F. Effects of intravenous infusion of a potassium-insulin-glucose solution on the electrographic signs of myocardial infarction. Am J Cardiol 1962;9:166-81.
2. Mittra B. Potassium, glucose, and insulin in treatment of acute myocardial infarction. Lancet 1965;2:607-9.
3. Pentecost BL, Mayne NM, Lamb P. Controlled trial of intravenous glucose, potassium, and insulin in acute myocardial infarction. Lancet 1968;1:946-8.
4. Medical Research Council Working Party on the Treatment of Myocardial Infarction. Potassium, glucose and insulin in the treatment for acute myocardial infarction. Lancet 1968;2:1355-60.
5. Fath-Ordoubadi F, Beatt KJ. Glucose-insulin-potassium therapy for the treatment of acute myocardial infarction: an overview of randomized placebo-controlled trials. Circulation 1997;96:1152-6.
6. Heng MK, Norris RM, Singh BN, Barratt Boyes C. Effects of glucose and glucose-insulin-potassium on haemodynamics and enzyme release after acute myocardial infarction. Br Heart J 1977;39:748-57.
7. Rogers WJ, Stanley AW, Breinig JB, et al. Reduction of hospital mortality rate of acute myocardial infarction with glucose-insulin-potassium infusion. Am Heart J 1976;92:441-54.
8. Stanley AW, Prather JW. Glucose-insulin-potassium, patient mortality and the acute myocardial infarction: results from a prospective randomized study. Circulation 1978;57 Suppl II:II62.
9. Satler LF, Green CE, Kent KM, Pallas RS, Pearle DL, Rackley CE. Metabolic support during coronary reperfusion. Am Heart J 1987;114:54-8.
10. Rackley CE, Russell RO, Rogers WJ, Mantle JA, McDaniel HG, Papapietro SE. Clinical experience with glucose-insulin-potassium therapy in acute myocardial infarction. Am Heart J 1981;102:1038-49.
11. Opie LH. Metabolism of free fatty acids, glucose and cathecholamines in acute myocardial infarction. Am J Cardiol 1975;36:938-53.
12. Oliver MF, Opie LH. Effects of glucose and fatty acids on myocardial ischaemia and arrhythmias. Lancet 1994;343:155-8.
13. Cave AC, Ingwall JS, Friedrich J, et al. ATP synthesis during low-flow ischemia: influence of increased glycolytic substrate. Circulation 2000;101:2090-6.
14. Apstein CS, Gravino FN, Haudenschild CC. Determinants of a protective effect of glucose and insulin on the ischemic myocardium. Circ Res 1983;52:515-26.
15. Grines CL, Browne KF, Marco J, et al. A comparison of immediate angioplasty with thrombolytic therapy for acute myocardial infarction. N Eng J Med 1993;328:673-9.
16. Zijlstra F, de Boer MJ, Hoorntje JC, Reiffers S, Reiber JH, Suryapranata H. A comparison of immediate coronary angioplasty with intravenous streptokinase in acute myocardial infarction. N Engl J Med 1993;328:680-4.
17. Zijlstra F, Hoorntje JC, de Boer MJ, et al. Long-term benefit of primary angioplasty as compared with thrombolytic therapy for acute myocardial infarction. N Engl J Med 1999;341:1413-9.
18. Vanoverschelde JL, Janier MF, Bakke JE, Marshall DR, Bergmann SR. Rate of glycolysis during ischemia determines extent of ischemic injury and functional recovery after reperfusion. Am J Physiol 1994;267:H1785-94.
19. Diaz R, Paolasso EA, Piegas LS, et al. Metabolic modulation of acute myocardial infarction: the ECLA (Estudios Cardiologicos Latino-america) collaborative group. Circulation 1998;98:2227-34.
20. Malmberg K, Efendic S, Ryden LE. Feasibility of insulin-glucose infusion in diabetic patients with acute myocardial infarction: a report from the multicenter trial: DIGAMI. Diabetes Care 1994;17:1007-14.
21. The TIMI Study Group. The Thrombolysis In Myocardial Infarction (TIMI) trial: phase I findings. N Engl J Med 1985;312:932-6.
22. van't Hof AW, Liem A, Suryapranata H, Hoorntje JCA, de Boer MJ, Zijlstra F. Angiographic assessment of myocardial reperfusion in patients treated with primary angioplasty for acute myocardial infarction: myocardial blush grade. Zwolle Myocardial Infarction study group. Circulation 1998;16:2302-6.
23. Ceremuzynski L, Budaj A, Czepiel A, et al. Low-dose glucose-insulin-potassium is ineffective in acute myocardial infarction: results of a randomized multicenter PoI-GIK trial. Cardiovasc Drugs Ther 1999;13:91-9.
24. Sjöstrand F, Edsberg L, Hahn RG. Volume kinetics of glucose solutions given by intravenous infusion. Br J Anaesth 2001;87:834-43.
25. Crexells C, Chatterjee K, Forrester JS, Dikshit K, Swan HJC. Optimal level of filling pressure in the left side of the heart in acute myocardial infarction. N Engl J Med 1973;289:1263-6.
26. Wildenthal K, Mierzwiak DS, Mitchell JH. Acute effects of increased serum osmolarity on left ventricular performance. Am J Physiol 1969;216:898-904.
27. Sasso FC, Carbonara O, Cozzolino D, et al. Effects of insulin-glucose infusion on left ventricular function at rest and during dynamic exercise in healthy subjects and noninsulin dependent diabetic patients: a radionuclide ventriculographic study. J Am Coll Cardiol 2000;36:219-26.
28. Mantle JA, Rogers WJ, Smith R, et al. Clinical effects of glucose-insulin-potassium on left ventricular function in acute myocardial infarction: results from a randomized clinical trial. Am Heart J 1981;102:313-24.
29. Whitlow PL, Rogers WJ, Smith LR, et al. Enhancement of left ventricular function by glucose-insulin-potassium infusion in acute myocardial infarction. Am J Cardiol 1982;45:721-6.
30. Malmberg K, Ryden L, Efendic S, et al. Randomized trial of insulin-glucose infusion followed by subcutaneous insulin treatment in diabetic patients wlth acute myocardial infarction (DIGAMI study): effects on mortality at 1 year. J Am Coll Cardiol 1995;26:57-65.
31. Groeneveld AB, Beishuizen A, Visser FC. Insulin: a wonder drug in the critically ill? Crit Care 2002;6:102-5.
32. Das UN. Is insulin an endogenous cardioprotector? Crit Care 2002;6:389-93.
33. van den Berghe G, Wouters P, Weekers F, et al. Intensive insulin therapy in the critically ill patients. N Engl J Med 2001;345:1359-67.
34. Eberli FR, Weinberg EO, Grice WN, Horowitz GL, Apstein CS. Protective effect of increased glycolytic substrate against systolic and diastolic dysfunction and increased coronary resistance from prolonged global underperfusion and reperfusion in isolated rabbit hearts perfused with erythrocyte suspensions. Circ Res 1991;68:466-81.